ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Senate Approves $47 Million For More AIDs Drugs

September 19, 1986

HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report

July 10, 1998

Medicare Should Pay Routine Care For Patients in Trials: IOM.

January 7, 2000

Robert Day Named New Director At Hutchinson Center

June 19, 1981

Nutrition RFPs Will Really Be Grants, Gori Says

January 23, 1976

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

November 28, 2003